GlucoTrack
GCTK
6 hedge funds and large institutions have $40.1K invested in GlucoTrack in 2025 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 0 increasing their positions, reducing their positions, and 4 closing their positions.
50% more funds holding
Funds holding: 4 → 6 (+2)
50% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 4
0% less ownership
Funds ownership: 0% → 0% (-0%)
43% less capital invested
Capital invested by funds: $69.8K → $40.1K (-$29.7K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
+$36K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
+$15.6K |
| 3 |
Barclays
London,
United Kingdom
|
+$6.59K |
| 4 |
NFSG
Newbridge Financial Services Group
Boca Raton,
Florida
|
+$264 |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$132 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AF
Alerus Financial
Grand Forks,
North Dakota
|
-$52.4K |
| 2 |
VF
Virtu Financial
New York
|
-$9K |
| 3 |
HF
HRT Financial
New York
|
-$6K |
| 4 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$2.41K |
GCTK Hedge Fund Activity: Q2 2025 in Review
6 of the 7,613 institutional investors tracked by Wall St. Rank reported a position in GlucoTrack (GCTK) for Q2 2025, worth a combined $40.1K — down 43% from $69.8K a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new GCTK positions and 4 closed out — a net gain of 2 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Bank of America, opening a new position worth an estimated $36K. The largest seller was Alerus Financial, exiting entirely with an estimated $52.4K sold.
- 6 institutional investors held GlucoTrack (GCTK) as of Q2 2025, up from 4 in Q1 2025.
- Funds reported $40.1K of GlucoTrack stock for Q2 2025, down 43% quarter-over-quarter.
- 6 funds opened new GlucoTrack positions in Q2 2025 and 4 closed out, a net change of +2 holders.
- The largest GlucoTrack buyer in Q2 2025 was Bank of America, an estimated $36K added.
- The largest GlucoTrack seller in Q2 2025 was Alerus Financial, an estimated $52.4K sold.
Based on aggregated 13F filings for Q2 2025.